Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
2007

Defibrillation Testing of the Implantable Cardioverter Defibrillator

Sample size: 835 publication Evidence: moderate

Author Information

Author(s): Luis A. Pires

Primary Institution: Heart Rhythm Center, Division of Cardiovascular Medicine, Department of Medicine, StJohn Hospital and Medical Center, Detroit, MI

Hypothesis

Is intraoperative defibrillation testing necessary for all patients receiving an implantable cardioverter-defibrillator (ICD)?

Conclusion

Intraoperative defibrillation testing remains important to ensure the proper function of ICDs despite advancements in technology.

Supporting Evidence

  • ICD therapy has been shown to reduce the risk of sudden death and overall mortality.
  • Testing at the time of device implantation has been a standard of care for several years.
  • Advances in technology have led some to question the necessity of defibrillation testing.

Takeaway

Doctors test ICDs to make sure they work properly, but some think this might not be needed for everyone anymore.

Methodology

The study reviews clinical trials and data regarding the efficacy of ICDs and the necessity of defibrillation testing.

Potential Biases

There is a risk that non-electrophysiologists may not have adequate training for testing, potentially impacting patient outcomes.

Limitations

The study lacks prospective data on outcomes for patients whose devices are not tested intraoperatively.

Participant Demographics

The study involved a cohort of 835 consecutive patients undergoing ICD implantation.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication